LLY
Eli Lilly and Company
LLY has the edge over SENS overall, supported by lower modeled downside and stronger fundamentals.
SENS
Senseonics Holdings, Inc.
SENS's outlook is improving, though it still trails on the overall score.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
SENS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Unavailable |
SENS's revenue is currently strong, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
SENS PE Valuation
SENS has no meaningful PE right now: it lost money over the past year.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
SENS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect SENS's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over SENS on earnings quality, reporting a profit while its opponent remains loss making.
SENS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.27 | -$0.64 |
| Q2 2026 | -$2.20 | -$0.20 |
| Q1 2026 | -$1.97 | +$0.23 |
| Q4 2025 | -$1.66 | +$0.74 |
| Q3 2025 | -$1.63 | +$0.97 |
| Q2 2025 | -$2.00 | +$0.60 |
| Q1 2025 | -$2.20 | +$0.60 |
| Q4 2024 | -$2.40 | -$0.20 |
SENS is still losing money, but far less than before: $2.27 per share over the past year, against $32.20 at its worst in mid-2021.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY's revenue has grown year over year for 14 quarters in a row: $24.4B last quarter, up 39% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over SENS on profitability, with a higher operating margin.
SENS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $19.6M | +142% |
| Q2 2026 | $14.5M | +118% |
| Q1 2026 | $11.7M | +87% |
| Q4 2025 | $14.3M | +72% |
| Q3 2025 | $8.1M | +90% |
| Q2 2025 | $6.6M | +37% |
| Q1 2025 | $6.3M | +24% |
| Q4 2024 | $8.3M | +3.3% |
SENS has the edge over LLY on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -163% | +79 points |
| Q2 2026 | -248% | -33 points |
| Q1 2026 | -272% | -56 points |
| Q4 2025 | -147% | +25 points |
| Q3 2025 | -242% | +294 points |
| Q2 2025 | -215% | +185 points |
| Q1 2025 | -216% | +146 points |
| Q4 2024 | -172% | +40 points |
SENS's operating margin was −163% last quarter, up 79 points from the same quarter a year ago, near the top of its range since 2019.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over SENS on cash generation, producing positive trailing cash flow while its opponent burns cash.
SENS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$33.2M | -$17.2M |
| Q2 2026 | -$30.4M | -$21M |
| Q1 2026 | -$32.1M | -$15.6M |
| Q4 2025 | -$18.4M | -$4.1M |
| Q3 2025 | -$16M | -$1.4M |
| Q2 2025 | -$9.4M | +$3.8M |
| Q1 2025 | -$16.5M | +$4.1M |
| Q4 2024 | -$14.3M | +$957K |
SENS has burned cash in almost every quarter: −$114M over the past year, against −$56M the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over SENS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
SENS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +14% | +7.9M shares |
| 1 year | +46% | +20.8M shares |
| 3 years | +122% | +36.1M shares |
| 5 years | +497% | +54.7M shares |
SENS has 66M diluted shares, up 46% from a year ago.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
SENS Net Leverage
SENS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
SENS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.4 | Neutral |
| Stochastic | 63.0 | Neutral |
SENS's weekly RSI is 59 (neutral) and its Stochastic is 63 (neutral).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
SENS PE vs Healthcare Sector
SENS has no meaningful PE right now: it lost money over the past year.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over SENS on trend strength, trading above more of its moving averages.
SENS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.04 | 11% above |
| 20 week MA | $8.00 | 25% above |
| 50 week MA | $7.20 | 39% above |
| 100 week MA | $9.40 | 6.8% above |
| 200 week MA | $10.5 | 4.7% below |
SENS has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 4.7% below its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has finished every year since 2020 higher, and it's up 32% so far in 2026.
SENS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $18.1 | $18.2 | +0.4% |
| 2021 | $18.2 | $59.0 | +224% |
| 2022 | $59.0 | $20.4 | -65% |
| 2023 | $20.4 | $11.4 | -44% |
| 2024 | $11.4 | $11.8 | +3.9% |
| 2025 | $11.8 | $6.02 | -49% |
| 2026 YTD | $6.02 | $10.0 | +67% |
SENS has the edge over LLY on returns for 2026, with the stronger performance.